Parkinson’s Patients Show Elevated Levels of Specific Protein in Key Brain Area, Study Reports

Parkinson’s Patients Show Elevated Levels of Specific Protein in Key Brain Area, Study Reports
Alterations in certain types of fat in a brain area called the substantia nigra may result in elevated levels of the GPNMB protein and drive neurodegeneration in Parkinson’s disease patients, according to Harvard researchers. The study, titled “The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson’s disease patients and increases after lysosomal stress,” appeared in the journal Neurobiology of Disease. The GPNMB ... read more
Source: Parkinson’s News TodayPublished on 2018-08-29By Jose Marques Lopes, PhD